Literature DB >> 35918468

Preparation and Evaluation of Siderol Amorphous Solid Dispersions: Selection of Suitable Matrix/Carrier.

Maria Koromili1,2, Afroditi Kapourani1, Antigoni Koletti3,4, George Papandreou1, Andreana N Assimopoulou3,4, Diamanto Lazari2, Panagiotis Barmpalexis5,6.   

Abstract

The present study investigates the preparation of amorphous solid dispersions (ASD) for the ent-kaurane diterpenoid siderol (SDR). Initially, evaluation of the pure drug (isolated from Sideritis scardica) revealed that the API is a non-stable glass former, and hence the selection of a suitable ASD's matrix/carrier needs special attention. For this reason, four commonly used polymers and copolymers, namely poly(vinylpyrrolidone), copovidone, hydroxypropyl cellulose, and Soluplus® (SOL), were screened via film casting and crystal growth rate measurements. Amongst them, SOL showed the highest SDR's crystal growth rate reduction, and, since it was also miscible with the drug, it was selected for further testing. In this direction, SDR-SOL ASDs were successfully prepared via melt-quench cooling. These formulations showed full API amorphization, while good physical stability (i.e., a stable SDR amorphous dispersions) were obtained after storage for several months. Finally, evaluation of molecular interactions (with the aid of ATR-FTIR spectroscopy) showed strong H-bonds between SOL and SDR, while the use of molecular dynamics (MD) simulations unraveled the nature of these interactions. Therefore, based on the findings of the present work, SOL seems to be an appropriate matrix/carrier for the preparation of SDR ASDs, although further studies are needed in order to explore its full potentials.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  Amorphous solid dispersions; Molecular dynamics simulations; Molecular interactions; Siderol; Soluplus

Mesh:

Substances:

Year:  2022        PMID: 35918468     DOI: 10.1208/s12249-022-02368-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   4.026


  4 in total

Review 1.  Strategies to address low drug solubility in discovery and development.

Authors:  Hywel D Williams; Natalie L Trevaskis; Susan A Charman; Ravi M Shanker; William N Charman; Colin W Pouton; Christopher J H Porter
Journal:  Pharmacol Rev       Date:  2013-01       Impact factor: 25.468

2.  Evaluation of rivaroxaban amorphous solid dispersions physical stability via molecular mobility studies and molecular simulations.

Authors:  Afroditi Kapourani; Kalliopi Eleftheriadou; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Eur J Pharm Sci       Date:  2020-11-12       Impact factor: 4.384

3.  Molecular simulations for amorphous drug formulation: Polymeric matrix properties relevant to hot-melt extrusion.

Authors:  Panagiotis Barmpalexis; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Eur J Pharm Sci       Date:  2018-04-24       Impact factor: 4.384

Review 4.  Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca.

Authors:  Akosua B Anane-Adjei; Esther Jacobs; Samuel C Nash; Sean Askin; Ramesh Soundararajan; Mary Kyobula; Jonathan Booth; Andrew Campbell
Journal:  Int J Pharm       Date:  2021-12-18       Impact factor: 5.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.